vs
Akso Health Group（AHG）与Amentum Holdings, Inc.（AMTM）财务数据对比。点击上方公司名可切换其他公司
Amentum Holdings, Inc.的季度营收约是Akso Health Group的462.4倍（$3.2B vs $7.0M）。Amentum Holdings, Inc.净利率更高（1.4% vs -18.6%，领先19.9%）
阿克索健康集团是一家跨国医疗健康企业，专注于仿制药、非处方健康产品及医疗器械的研发、生产与分销，核心市场覆盖中国、东南亚及北美地区，业务范畴包含药品制造、医疗供应链及社区医疗服务板块。
本公司是总部位于美国达拉斯的跨国技术专业服务企业，面向全球企业、机构及政府部门客户提供工程、技术、建设服务以及科学与专项咨询服务，连续6年蝉联《工程新闻纪录》（ENR）全球顶尖设计企业500强榜首。
AHG vs AMTM — 直观对比
营收规模更大
AMTM
是对方的462.4倍
$7.0M
净利率更高
AMTM
高出19.9%
-18.6%
损益表 — Q2 2026 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $3.2B |
| 净利润 | $-1.3M | $44.0M |
| 毛利率 | 8.9% | 10.1% |
| 营业利润率 | -20.5% | 4.3% |
| 净利率 | -18.6% | 1.4% |
| 营收同比 | — | -5.2% |
| 净利润同比 | — | 266.7% |
| 每股收益（稀释后） | — | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AHGAMTM
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.9B | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | — | $3.6B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.1B |
净利润AHGAMTM
| Q1 26 | — | $44.0M | ||
| Q4 25 | — | $40.0M | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | — | $10.0M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | — | $12.0M | ||
| Q3 24 | — | $26.0M | ||
| Q2 24 | — | $-26.0M |
毛利率AHGAMTM
| Q1 26 | — | 10.1% | ||
| Q4 25 | — | 10.6% | ||
| Q3 25 | 8.9% | — | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.5% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 9.6% |
营业利润率AHGAMTM
| Q1 26 | — | 4.3% | ||
| Q4 25 | — | 3.4% | ||
| Q3 25 | -20.5% | — | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 4.2% |
净利率AHGAMTM
| Q1 26 | — | 1.4% | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | -18.6% | — | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | -1.2% |
每股收益（稀释后）AHGAMTM
| Q1 26 | — | $0.18 | ||
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.02 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | — | $0.31 | ||
| Q2 24 | — | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $247.0M |
| 总债务越低越好 | — | $3.9B |
| 股东权益账面价值 | $198.3M | $4.6B |
| 总资产 | $212.0M | $11.2B |
| 负债/权益比越低杠杆越低 | — | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资AHGAMTM
| Q1 26 | — | $247.0M | ||
| Q4 25 | — | $437.0M | ||
| Q3 25 | $11.1M | — | ||
| Q2 25 | — | $738.0M | ||
| Q1 25 | — | $546.0M | ||
| Q4 24 | — | $522.0M | ||
| Q3 24 | — | $452.0M | ||
| Q2 24 | — | — |
总债务AHGAMTM
| Q1 26 | — | $3.9B | ||
| Q4 25 | — | $3.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | — | $4.7B | ||
| Q3 24 | — | $4.7B | ||
| Q2 24 | — | — |
股东权益AHGAMTM
| Q1 26 | — | $4.6B | ||
| Q4 25 | — | $4.5B | ||
| Q3 25 | $198.3M | — | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $303.0M |
总资产AHGAMTM
| Q1 26 | — | $11.2B | ||
| Q4 25 | — | $11.5B | ||
| Q3 25 | $212.0M | — | ||
| Q2 25 | — | $11.8B | ||
| Q1 25 | — | $12.0B | ||
| Q4 24 | — | $11.9B | ||
| Q3 24 | — | $12.0B | ||
| Q2 24 | — | — |
负债/权益比AHGAMTM
| Q1 26 | — | 0.86× | ||
| Q4 25 | — | 0.88× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 1.06× | ||
| Q4 24 | — | 1.05× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.2M | $-136.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-142.0M |
| 自由现金流率自由现金流/营收 | — | -4.4% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | -3.09× |
| 过去12个月自由现金流最近4个季度 | — | $272.0M |
8季度趋势，按日历期对齐
经营现金流AHGAMTM
| Q1 26 | — | $-136.0M | ||
| Q4 25 | — | $270.0M | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | — | $106.0M | ||
| Q1 25 | — | $57.0M | ||
| Q4 24 | — | $110.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流AHGAMTM
| Q1 26 | — | $-142.0M | ||
| Q4 25 | — | $261.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $100.0M | ||
| Q1 25 | — | $53.0M | ||
| Q4 24 | — | $102.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率AHGAMTM
| Q1 26 | — | -4.4% | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度AHGAMTM
| Q1 26 | — | 0.2% | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率AHGAMTM
| Q1 26 | — | -3.09× | ||
| Q4 25 | — | 6.75× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.60× | ||
| Q1 25 | — | 14.25× | ||
| Q4 24 | — | 9.17× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AHG
暂无分部数据
AMTM
| Global Engineering Solutions Segment | $1.9B | 59% |
| Other U.S.Government Agencies | $400.0M | 12% |
| Fixed Price Contract | $380.0M | 12% |
| Commercial And International | $226.0M | 7% |
| Time And Materials Contract | $171.0M | 5% |
| Sales Channel Through Intermediary | $78.0M | 2% |
| Equity Method Investee | $50.0M | 2% |
